<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01127282</url>
  </required_header>
  <id_info>
    <org_study_id>Vitamin_H1N1</org_study_id>
    <nct_id>NCT01127282</nct_id>
  </id_info>
  <brief_title>The Impact of Vitamin on the Clinical Course in Cases Infected by Novel H1N1 Influenza Virus A</brief_title>
  <official_title>The Impact of Vitamin on the Clinical Course in Cases Infected by Novel H1N1 Influenza Virus A: a Randomized-controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Influenza continues to inflict an important burden on health-care systems. The 2009 H1N1
      influenza virus first appeared in Mexico and the United States in March and April 2009 and
      has swept the globe with unprecedented speed.

      The aim of this study is to evaluate effect of supplement vitamin on the clinical course of
      patients with acute respiratory illness suspected novel H1N1 infection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with acute respiratory illness randomized to control or vitamin groups. The patients
      completed questionnaire about their initial symptom scores. After 5 days of vitamin trial,
      patients were asked about their symptom by telephone survey.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2009</start_date>
  <completion_date type="Anticipated">August 2010</completion_date>
  <primary_completion_date type="Anticipated">June 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change of symptom score</measure>
    <time_frame>1 week after initial visit</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>H1N1 Influenza</condition>
  <arm_group>
    <arm_group_label>Vitamin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitamin(vitamin A 15mg,C 500mg,E 400IU) 1T po for 5 days in addition to anti-viral agent and antipyretics</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo(digestive tablet) 1T po for 5 days in addition to anti-viral agent and antipyretics</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin (vitamin A 15 mg,C 500 mg, E 400IU)</intervention_name>
    <description>Vitamin (vitamin A 15 mg,C 500 mg, E 400IU) 1T po for 5 days in addition to anti-viral agent and antipyretics</description>
    <arm_group_label>Vitamin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo (digestive tablet)</intervention_name>
    <description>Placebo (digestive tablet) 1T po for 5 days in addition to anti-viral agent and antipyretics</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 20 years

          -  Acute respiratory illness suspected H1N1 infection

          -  Acute febrile respiratory illness(BT &gt; 37.8) and throat pain or cough or nasal
             congestion

        Exclusion Criteria:

          -  Pregnancy

          -  Hypersensitivity to vitamin A

          -  History of liver disease or renal disease

          -  Urinary stone disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chang-Hoon Lee, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul Metropolitan Government, Seoul National University Boramae Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chang-Hoon Lee, MD</last_name>
    <phone>+82- 2- 870- 2232</phone>
    <email>kauri670@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jong Sun Park, MD</last_name>
    <email>jspark.im@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul Metropolitan Government, Seoul National University Boramae Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>156-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chang-Hoon Lee, MD</last_name>
      <phone>+82- 2- 870- 2232</phone>
      <email>kauri670@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 19, 2010</study_first_submitted>
  <study_first_submitted_qc>May 19, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 20, 2010</study_first_posted>
  <last_update_submitted>May 19, 2010</last_update_submitted>
  <last_update_submitted_qc>May 19, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 20, 2010</last_update_posted>
  <responsible_party>
    <name_title>Chang-Hoon Lee</name_title>
    <organization>Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul Metropolitan Government, Seoul National University Boramae Medical Center</organization>
  </responsible_party>
  <keyword>influenza</keyword>
  <keyword>vitamin</keyword>
  <keyword>improvement of symptom</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Influenza, Human</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin A</mesh_term>
    <mesh_term>Retinol palmitate</mesh_term>
    <mesh_term>Antiviral Agents</mesh_term>
    <mesh_term>Antipyretics</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>April 13, 2011</submitted>
    <returned>May 9, 2011</returned>
    <submitted>June 6, 2011</submitted>
    <returned>June 24, 2011</returned>
    <submitted>February 14, 2014</submitted>
    <returned>March 29, 2014</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

